Cellerant Therapeutics Inc — Form D/A

Cellerant Therapeutics Inc of SAN CARLOS, CA, a company, filed a Form D amendment with the SEC on 2019-02-12. The offering totals $10.0M, of which $6.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Stephen GreenbergDirectorNew York, NY
Robby HogleDirectorSan Carlos, CA
Ramkumar MandalamDirectorSan Carlos, CA
Richard G RathmannDirectorSan Carlos, CA
GISELA SCHWABDirectorCAMBRIDGE, MA
Ramkumar MandalamExecutive OfficerSan Carlos, CA
Rodney YoungExecutive OfficerSan Carlos, CA
Lowell SearsDirectorSan Carlos, CA
Richard ChyetteDirectorLivonia, MI
Richard G ChyetteDirectorLivonia, MI
Lowell G SearsDirectorSan Carlos, CA
Stephen G GreenbergDirectorNew York, NY
Gisela G SchwabDirectorSan Carlos, CA
Antoun G NabhanDirectorSan Francisco, CA
Gisela G. SchwabDirectorSan Carlos, CA
Lowell G. SearsDirectorSan Carlos, CA
Richard G. RathmannDirectorAnnapolis, MD
Richard G. ChyetteDirectorLivonia, MI
Stephen G. GreenbergDirectorNew York, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2016-04-13D$2.0M$2.0M
2014-01-22D$2.2M$2.2M
2012-09-24D$2.1M$2.1M
2011-08-31D$1.6M$800K
2011-04-21D/A$2.0M$2.0M
2010-12-29D$2.5M$1.0M
2010-06-30D/A$4.5M$4.5M
2010-02-09D$4.5M$2.3M

More